{
    "organizations": [],
    "uuid": "11b0d9f4e43f758cb3d59fa34edcc577e4be0ec3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-guangdong-zhongsheng-pharmaceutica/brief-guangdong-zhongsheng-pharmaceutical-gets-approval-to-issue-medium-term-notes-idUSH9N1QH03M",
    "ord_in_thread": 0,
    "title": "Guangdong Zhongsheng Pharmaceutical Gets Approval To Issue Medium-Term Notes",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 1 (Reuters) - Guangdong Zhongsheng Pharmaceutical Co Ltd:\n* SAYS IT GETS APPROVAL TO ISSUE 1.3 BILLION YUAN ($204.89 million) MEDIUM-TERM NOTES Source text in Chinese: bit.ly/2GVC6iT ($1 = 6.3450 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)\n ",
    "published": "2018-03-01T18:57:00.000+02:00",
    "crawled": "2018-03-02T19:50:12.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "guangdong",
        "zhongsheng",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "get",
        "approval",
        "issue",
        "billion",
        "yuan",
        "million",
        "note",
        "source",
        "text",
        "chinese",
        "chinese",
        "yuan",
        "renminbi",
        "reporting",
        "hong",
        "kong",
        "newsroom"
    ]
}